Generation of chimeric toxins.
FitzGerald
D
D
Laboratory of Molecular Biology, National Cancer Institute, National Institutes of Health, Bethesda, Maryland.
Chaudhary
V K
VK
Kreitman
R J
RJ
Siegall
C B
CB
Pastan
I
I
D000818:Animals; D000998:Antiviral Agents / Q000494:pharmacology; D002460:Cell Line; D003001:Cloning, Molecular; D006801:Humans; D000922:Immunotoxins / Q000235:genetics* / Q000627:therapeutic use / Q000633:toxicity; D015850:Interleukin-6 / Q000627:therapeutic use; D015375:Receptors, Interleukin-2 / Q000187:drug effects; D011993:Recombinant Fusion Proteins / Q000235:genetics / Q000627:therapeutic use / Q000633:toxicity; D016211:Transforming Growth Factor alpha / Q000627:therapeutic use
D000998:Antiviral Agents; D000922:Immunotoxins; D015850:Interleukin-6; D015375:Receptors, Interleukin-2; D011993:Recombinant Fusion Proteins; D016211:Transforming Growth Factor alpha